Gallus Biopharmaceuticals to Retain/Add 320 Jobs in Missouri
05/22/2011
Recently Gallus purchased the former 15-acre, 200,000-square-foot Centocor Biologics facility in Berkeley. The company plans to make an initial capital investment of $20 million to expand the facility, hire about 160 Centocor employees; and create about 160 new jobs over the next five years. The average salary is expected to be $88,500.
Gallus Biopharmaceuticals is a contract manufacturer of pharmaceuticals produced from cell cultures. It plans on expanding the commercially certified, FDA-approved facilities at the former Centocor plant by building a clinical services suite, expanding the existing development lab and fitting out a commercial suite.
The state of Missouri awarded Gallus a $14.6 million economic incentive package, redeemable over the next 10 years.
Project Announcements
Teradyne Plans Wixom, Michigan, Robotics Operations
12/11/2025
Robinson Plans Altoona, Iowa, Manufacturing Operations
12/11/2025
BioTouch Expands Columbus, Georgia, Operations
12/11/2025
Natrion Plans Erie County, New York, Battery Components Operations
12/11/2025
Czech-Based GZ PrintPak Expands Mount Pleasant, Wisconsin, Manufacturing Operations
12/11/2025
Dubai-Based Asis Boats USA Plans Conway, South Carolina, Operations
12/10/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
How Canada Stays Competitive
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025